Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
50.8M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$439M
-
Value change
-
-$16.2M
-
Put/Call ratio
-
0
-
Number of buys
-
41
-
Number of sells
-
-55
-
Price
-
$8.63
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q3 2023
133 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q3 2023.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.8M shares
.
Largest 10 shareholders include Weiss Asset Management LP (7.46M shares), BAUPOST GROUP LLC/MA (7.42M shares), Madison Avenue Partners, LP (7.01M shares), BlackRock Inc. (4.57M shares), VANGUARD GROUP INC (3.84M shares), Irenic Capital Management LP (2.76M shares), Pictet Asset Management Holding SA (2.01M shares), Park West Asset Management LLC (1.98M shares), Newtyn Management, LLC (1.84M shares), and STATE STREET CORP (1.47M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.